Antigua and Barbuda Eyes Cannabis Tourism Market, Report Says

A headline, not yet a program

Antigua and Barbuda's cannabis tourism ambition is real as a headline, but the details that would make it investable haven't surfaced.

Tourism Review Media reported on Nov. 1, 2026 that the country is eyeing the cannabis tourism market. The summary available to CannIntel includes no bill number, no licensing timeline, no named minister and no dollar figure. We won't invent any.

What exists is a legal base. Antigua and Barbuda passed a Cannabis Act in 2018 that decriminalized small-quantity possession and set up a regulatory authority to handle licensing. That's a start. It isn't a tourism product.

My thesis: this is a regulatory story dressed as a marketing story. The island doesn't need a better slogan. It needs a rulebook that tells a visitor from Toronto or London what's legal on arrival.

The Jamaica test

Jamaica's head start shows cannabis tourism pays only when licensed, tourist-facing activity is clearly legal.

The obvious comparison is Jamaica. Its 2015 amendments decriminalized small amounts and created the Cannabis Licensing Authority, which gave operators a path to offer legal, visitor-oriented experiences. Decriminalization alone didn't build that market. Licensing did.

Here's why that matters for Antigua and Barbuda. A law built around personal possession and home cultivation serves residents. A tourist staying in a hotel has no garden and no dealer they can legally trust. Without a licensed retail or experience channel, visitor demand flows to the gray market. That's bad for safety, and worse for tax revenue.

The island that wins cannabis tourism won't be the one with the best beaches. It'll be the one that tells a visitor, in writing, where purchase and consumption are legal.

Before anyone prices this opportunity, four questions need answers from Saint John's:

• Will licenses cover tourist-facing retail or only medical and sacramental use?
• Where, if anywhere, is public or hotel consumption allowed?
• How will the authority handle quality testing and traceability?
• What guidance will visitors get on carrying product through airports?

Those aren't details. They're the business model.

Who actually profits

The money in Caribbean cannabis tourism will likely go to licensed local operators and foreign investors who can legally hold plant-touching assets, not US-listed MSOs.

Read this tactically and the competitive picture is lopsided. US multistate operators carry federal exposure at home, and under 280E they're already squeezed on margins. Cross-border plant-touching expansion is a legal and financing headache for them. I wouldn't bet on MSO capital flowing into island dispensaries, and Antigua and Barbuda shouldn't build its pitch around it.

The more plausible winners sit elsewhere. Locally owned operators, hospitality groups willing to partner with licensed cultivators, and investors from jurisdictions like Canada that already treat cannabis as a regulated consumer industry are better positioned. Brand licensing and consumer-facing partnerships are the capital-light version for any US name that wants exposure. That's my read, not a reported plan.

Antigua and Barbuda also enters a crowded field. Jamaica has years of operating history and name recognition, which is hard to displace with a late start. A small market can still carve a niche, but only by being specific: a defined license class, clear consumption rules, and a credible compliance story that cruise lines and resort operators can underwrite.

For full background on how regional rules are shaping visitor demand, see the CannIntel topic hub on Caribbean cannabis tourism.

The next signal: whether the government publishes draft regulations or a licensing category aimed at visitors. Until that document exists, treat Antigua and Barbuda's cannabis tourism pitch as intent, not an investable market.